title: Payer perspectives on federally funded comparative effectiveness research.
abstract: Comparing the effectiveness of drugs and their costs is not new for payers, whose criteria may include factors not considered by investigators performing federally funded CER. Here are the surprising results of a survey of payer views on the impact of federal CER on specialty drugs.
authors.forename: Sarah
authors.initials: S
authors.lastname: Collins